Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors

חו"ל (דורש נסיעה)מגייס משתתפיםPHASE1

מצבים רפואיים

Head and Neck Squamous Cell Carcinoma · Squamous Cell Carcinoma of Anal Canal · Colorectal Cancer · Squamous Cell Carcinoma of the Lung · EGFR Amplification · Epithelial Ovarian Cancer · Pancreas Cancer · Cutaneous Squamous Cell Carcinoma · Head and Neck Neoplasms · Carcinoma, Squamous Cell · Squamous Cell Carcinoma of Head and Neck

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים
  • Moores Cancer Center UC San Diego Health, La Jolla, California, United States

    Contact: Study coordinator (Debanjali Ghosh) · d1ghosh@health.ucsd.edu · 858.246.0357
    Contact: Principal Investigator (Assuntina Sacco, MD)
  • Keck School of Medicine of USC, Los Angeles, California, United States

    Contact: Principal Investigator (Gino In, MD)
  • UCLA, Los Angeles, California, United States

    Contact: Principal Investigator (Deborah Wong, MD)
  • University of California, Davis Comprehensive Cancer Center, Sacramento, California, United States

    Contact: Study coordinator (Andrew Birkeland, MD)
    Contact: Principal Investigator (Andrew Birkeland, MD)
  • H. Lee Moffitt Cancer Center and Research Institute, Inc, Tampa, Florida, United States

    Contact: Study coordinator (Hamza Elmohd) · Hamza.elmohd@moffitt.org · (813)-745-5554
    Contact: Principal Investigator (Christine Chung, MD)
  • Dana Farber/Partners Cancer Care Inc, Boston, Massachusetts, United States

    Contact: Study coordinator (DFCI Clinical Trials Hotline) · 8773387425
    Contact: Principal Investigator (Glenn Hanna, MD)
  • Memorial Sloan Kettering, New York, New York, United States

    Study coordinator · 646-608-3759
    Contact: Principal Investigator (Paul Paik, MD)
  • Columbia University Herbert Irving Comprehensive Cancer Center, New York, New York, United States

    Contact: Study coordinator (CPDM Nurse Navigator) · cancerclinicaltrials@cumc.columbia.edu · 2123425162
    Contact: Principal Investigator (Catherine Shu, MD)
  • Levine Cancer Institute, Charlotte, North Carolina, United States

    Contact: Study coordinator (Daniel R Carrizosa, MD, MS, FACP) · 980-442-3213
  • Cleveland Clinic, Cleveland, Ohio, United States

    Study coordinator · TaussigResearch@ccf.org · (866) 223-8100
    Contact: Principal Investigator (Tamara Sussman, MD)
  • UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania, United States

    Contact: Study coordinator (Sarah Brodeur) · brodeurs@upmc.edu
    Contact: Principal Investigator (Dan Zanberg, MD)
  • Rhode Island Hospital, Providence, Rhode Island, United States

    Contact: Principal Investigator (Ariel Birnbaum, MD)
  • Medical University of South Carolina, Hollings Cancer Center, Charleston, South Carolina, United States

    Contact: Study coordinator (Lilli Neal) · nealli@musc.edu · 8437928113
    Contact: Study coordinator (Carly Fecio) · fecio@musc.edu · 8437923479
    Contact: Principal Investigator (John Kaczmar, MD)
  • Vanderbilt University Medical Center, Nashville, Tennessee, United States

    Contact: Principal Investigator (Jennifer Choe, MD, PhD)
  • MD Anderson Cancer Center, Houston, Texas, United States

    Contact: Study coordinator (Beryl Tross) · bmtross@mdanderson.org · 7137450774
    Contact: Principal Investigator (Van Morris, MD)
  • Chris O'Brien Lifehouse, Camperdown, New South Wales, Australia

    Contact: Study coordinator (Jenny Lee, MBBS, FRACP)
    Contact: Principal Investigator (Jenny Lee, MBBS, FRACP)
  • Calvary Mater Newcastle, Waratah, New South Wales, Australia

    Study coordinator · +61 2 40143590
    Contact: Principal Investigator (Fiona Day)
  • Austin Hospital, Heidelberg, Victoria, Australia

    Contact: Study coordinator (Alesha Thai, MBBS, FRACP, PhD) · +61394965000
  • Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia

    Study coordinator · +61 3 8559 5000
    Contact: Principal Investigator (Danny Rischin, MD)
  • Princess Margaret Cancer Centre, Toronto, Ontario, Canada

    Study coordinator · 18007110500
    Contact: Principal Investigator (Phillippe Bedard, MD)